Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology) - Image 1

£71.91

Springer Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Name: Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
Brand: Springer
Price: 71.91 GBP
Availability: InStock

Oncology

Price History & Forecast

Last 89 days • 89 data points

Historical

Generating forecast...

Price Distribution

Price distribution over 89 days • 1 price levels

Days at Price

Price Analysis

Most common price: £72 (89 days, 100.0%)

Price range: £72 - £72

Price levels: 1 different prices over 89 days

Description

Product Description Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers. Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development gathers all of the molecular and cellular aspects of gynecological cancer together within one volume, providing detailed and up-to-date information on the etiology, diagnosis, and treatment of gynecological cancers. Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development also discusses the racial and ethnic disparities in the treatment of gynecological cancers through cost effective modalities like single visit screening and diagnosis, well women clinics, and mobile clinics. Written and edited by leaders in the field, this volume within the Current Clinical Oncology series is an indispensable resource for today’s practicing oncologist. From the Back Cover Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers. Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development gathers all of the molecular and cellular aspects of gynecological cancer together within one volume, providing detailed and up-to-date information on the etiology, diagnosis, and treatment of gynecological cancers. Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development also discusses the racial and ethnic disparities in the treatment of gynecological cancers through cost effective modalities like single visit screening and diagnosis, well women clinics, and mobile clinics. Written and edited by leaders in the field, this volume within the Current Clinical Oncology series is an indispensable resource for today’s practicing oncologist. About the Author Antonio Giordano, MD, PhD Professor Temple University Sbarro Institute for Cancer Research and Molecular Medicine and Center of Biotechnology Department of Biology Philadelphia, PA, USA Marcella Macaluso, PhD Associate Professor Temple University Sbarro Institute for Cancer Research and Molecular Medicine and Center of Biotechnology Department of Biology Philadelphia, PA, USA

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3319329057
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 08 September 2016
Listed Since: 15 March 2016

Barcode

No barcode data available

Springer Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Praxisbuch Gynäkologische Onkologie

Cell Signaling & Molecular Targets in Cancer

Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)

Cell Signaling & Molecular Targets in Cancer

Clinical Ophthalmic Oncology: Retinoblastoma

Precision Medicine in Oncology

Cervical Cancer: From Etiology to Prevention: 2 (Cancer Prevention-Cancer Causes, 2)

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)

Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Beyond Our Genes: Pathophysiology of Gene and Environment Interaction and Epigenetic Inheritance

HPV and Cervical Cancer: Achievements in Prevention and Future Prospects

Clinical Oncology and Error Reduction

Practical Guide to Hereditary Breast and Ovarian Cancer III: Annual Meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2023: 3

Retinoids in Oncology (ESO Monographs)

Frontiers in Cancer Research: Evolutionary Foundations, Revolutionary Directions

Breast Cancer Pathophysiology: An Interdisciplinary Approach: 5 (Interdisciplinary Cancer Research, 5)

Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)

Cancer II: 28 (Topics in Medicinal Chemistry, 28)

Current Problems in the Epidemiology of Cancer and Lymphomas: Symposium of the "Gesellschaft zur Bekämpfung der Krebskrankheiten Nordrhein-Westfalen ... 39 (Recent Results in Cancer Research, 39)

Genetic Causes of Cardiac Disease: 7 (Cardiac and Vascular Biology, 7)